Evidence map›Paper›PMID 29263649›Full record

ReviewDrug design, development and therapy2017

Regulation profile of the intestinal peptide transporter 1 (PepT1).

Chun-Yang Wang, Shu Liu, Xiao-Nv Xie, Zhi-Rong Tan

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Functional Effects ofInternational journal of molecular sciences · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparative Gut Proteome ofMicroorganisms · 2025
    Article
  15. Quantification of Peptides in Food Hydrolysate fromFoods (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chun-Yang WangDepartment of Clinical Pharmacology, Xiangya Hospital, Xiangya School of Medicine, Central South University.
Shu LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Xiangya School of Medicine, Central South University.
Xiao-Nv XieDepartment of Clinical Pharmacology, Xiangya Hospital, Xiangya School of Medicine, Central South University.
Zhi-Rong TanDepartment of Clinical Pharmacology, Xiangya Hospital, Xiangya School of Medicine, Central South University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal peptide transporter 1 (PepT1) was first identified in 1994. It plays a crucial role in the absorption of small peptides including not only >400 different dipeptides and 8,000 tripeptides digested from dietary proteins but also a repertoire of structurally related compounds and drugs. Owing to its critical role in the bioavailability of peptide-like drugs, such as the anti-cancer agents and anti-virus drug, PepT1 is increasingly becoming a striking prodrug-designing target. Therefore, the understanding of PepT1 gene regulation is of great importance both for dietary adaptation and for clinical drug treatment. After decades of research, it has been recognized that PepT1 could be regulated at the transcriptional and post-transcriptional levels by numerous factors. Therefore, the present review intends to summarize the progress made in the regulation of PepT1 and provide insights into the PepT1's potential in clinical aspects of nutritional and drug therapies.

Indexed as

AnimalsGene Expression RegulationHumansIntestinal MucosaPeptide Transporter 1Peptide Transporter 1absorptionbioavailabilitydietaryPepT1regulationtransport activity

Identifiers

PMID29263649
PMCPMC5726373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.